RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates
RxSight (RXST) delivered earnings and revenue surprises of +87.14% and +0.02%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?